MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Sub-specialties: Heart Failure
Conditions Treated by this Doctor:
General Cardiology, Heart Failure.
Dr Carolyn Lam is a Senior Consultant of the National Heart Centre, Singapore; Professor of Duke-NUS Cardiovascular Academic Clinical Program; Scientific Advisor to the Clinical Trials Coordinating Centre at SingHealth, Research EXCO member of the SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme, and Affiliate Member of the SingHealth Duke-NUS Institute of Precision Medicine. She graduated from the Faculty of Medicine, National University of Singapore, completed advanced specialty training in Cardiology in Singapore, and pursued her Research Fellowship at the Cardiorenal Laboratory, Heart Failure Fellowship at the Division of Cardiovascular Diseases, and Advanced Cardiology and Master of Biomedical Sciences at Mayo Clinic, Rochester MN. She received further training in clinical and genetic epidemiology at the Framingham Heart Study in Boston, MA, graduated from the Stanford Executive Programme and obtained her PhD at University Medical Centre Groningen.
Dr Lam's clinical sub-specialty is heart failure, and she is recognized globally for her expertise in heart failure with preserved ejection fraction. She also has expertise in women's cardiovascular disease, hemodynamics, echocardiography, biomarkers and clinical trials. She started the first Heart Failure with Preserved Ejection Fraction Programme and Women's Heart Health Clinic in Singapore. She has been recognized by numerous awards, including the L'Oreal Women In Science Award (2012), InterAcademy Medical Panel Young Physician Leader – Berlin (2012), the award for the Junior Chamber International (JCI) Ten Outstanding Young Persons of the World for 2014 – Singapore (2014), and SingHealth GCEO – Outstanding Clinical Researcher Award (2019). She is also a current recipient of the NMRC Senior Investigator Clinician Scientist Award.
Dr Lam is the Programme Lead of the Asian neTwork for Translational Research and Cardiovascular Trials (ATTRaCT) – an A*STAR Biomedical Research Council-funded research platform winning the A*STAR Awards - Borderless Award (2019), Principal Investigator of a multinational Asian study of heart failure across 11 Asian countries (Asian Sudden Cardiac Death in Heart Failure [ASIAN-HF] study), and fellow of multiple organizations including the American College of Cardiology, the European Society of Cardiology, the ASEAN Federation of Cardiology, and the Academy of Medicine Singapore. She is a member of the Royal College of Physicians, the HFpEF Committee for the Heart Failure Association of the European Society of Cardiology, the International Federation of Clinical Chemistry & Laboratory Medicine Task Force, and the Committee of the Education & Management Division on Clinical Applications of Cardiac Bio-Markers for the International Federation of Clinical Chemistry. She has published more than 200 articles and review articles in journals including New England Journal of Medicine, JAMA, Lancet, Circulation, Journal of the American College of Cardiology, and European Heart Journal. She serves as a consultant on several global advisory boards for cardiovascular disease, as a member of the Executive Committees of global heart failure trials, and as an Associate Editor for Circulation and the European Journal of Heart Failure. Finally, Dr Lam is heard weekly on the global podcast "Circulation On The Run" and seen regularly on television as the Resident Doctor of the health programme "Body and Soul" by MediaCorp Singapore.
Subscribe to our mailing list to get the updates to your email inbox...